IDERA PHARMACEUTICALS, INC. vs NEUROCRINE BIOSCIENCES INC, risk disclosures compared

4topics both disclose

2only IDERA PHARMACEUTICALS, INC.

10only NEUROCRINE BIOSCIENCES INC

What both disclose

Topics appearing in filings from both companies, and how many filings each.

Topic	IDERA PHARMACEUTICALS, INC.	NEUROCRINE BIOSCIENCES INC
Internal Control	4	1
Enforcement Action	3	1
Restatement	1	3
Regulatory Reporting	1	1

Only IDERA PHARMACEUTICALS, INC.

Topic	Filings
Material Weakness	4
Consent Order	1

Only NEUROCRINE BIOSCIENCES INC

Topic	Filings
Ransomware	18
Cross Border Data Transfer	14
Business Continuity	3
Vendor Risk Management	3
AI Governance	1
Artificial Intelligence	1
Data Breach	1
Identity And Access Management	1
Records Retention	1
Third Party Risk Management	1

What this compares

Which of the topics we track appear in each company's SEC filings, and how often. A topic appearing for one company and not the other means one wrote the phrase down and the other did not, in the filings we hold. It does not mean one faces a risk the other does not, and it is not a comparison of how well either manages anything.

Counts reflect the filings we have collected, which is a growing subset rather than a company's complete history.

IDERA PHARMACEUTICALS, INC. · NEUROCRINE BIOSCIENCES INC · All companies